XJPX
3417
Market cap124mUSD
Dec 05, Last price
1,421.00JPY
1D
0.00%
1Q
3.50%
Jan 2017
175.39%
IPO
206.91%
Name
Ohki Healthcare Holdings Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ohki Healthcare Holdings Co.,Ltd. distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities. The company imports, exports, and sells pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and deleterious substances, drugs, reagents, measuring instruments, optical instruments, electrical products, communication equipment, veterinary drugs, veterinary medical equipment, pet supplies, feed, feed additives, textile products, sanitary products, beauty and health equipment, sports equipment, leisure goods, nursing goods, nursing convenience goods, toys, stationery, homes supplies, daily necessities, groceries, food additives, alcoholic beverages, rice grains, salt, and cigarettes. It also provides chemicals, fertilizers, pesticides, gardening supplies, and agricultural supplies, as well as engages in the warehousing, information processing systems, distribution system equipment, and software development activities. In addition, the company engages in the pharmacy/drug store management and dispensing service, and nursing service businesses; manufacture and sale of pharmaceuticals, quasi-drugs, cosmetics, health foods, killing agents, medical and sanitary products, soft drinks, medical skin care, health food, and miscellaneous goods. Further, it is involved in the manufacture and wholesale of environmental conservation products; and wholesale of food and contact products, cosmetics, and miscellaneous goods, as well as license application agency business. The company was founded in 1658 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||